Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Black cumin seed oil extract (thymoquinone)

Black Seed Oil (Thymoquinone / Nigella Sativa) · also known as Black seed oil, Thymoquinone, Thymoquinone, Nigella Sativa Oil

Thymoquinone is the main active compound in black cumin seed oil. Its effects on stabilizing mast cells and suppressing inflammatory mediators come mainly from animal and cell studies. The strength of its effect in humans and the appropriate dose are still unclear, and the thymoquinone content of the oil varies widely with the raw material and processing.

Typical dose: Cold-pressed black cumin seed oil: 1000–2000 mg/day, or standardized thymoquinone: 20–50 mg/day. The latter lacks adequate long-term human dosing data, so consult a doctor before using it.
Absorption and forms: Thymoquinone content in cold-pressed black cumin seed oil varies with raw material and processing, so it cannot be assumed to be a uniform 0.5%–1.5%. Standardized thymoquinone extracts have more controlled content and are best taken with a meal that contains healthy fats.

Clinical uses and human evidence

High LDL cholesterol

BeneficialGrade B · Moderate evidence
Studies (2)
  1. Rounagh 2024 · Clin Nutr ESPEN · Meta-analysis · n=2278 — Effects of Nigella sativa supplementation on lipid profiles in adults: An updated systematic review and meta-analysis of randomized controlled trials
  2. Hadi 2021 · Phytother Res · RCT · n=43 — Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial

Blood sugar and insulin resistance

BeneficialGrade B · Moderate evidence
Studies (2)
  1. Musazadeh 2026 · Endocrinol Diabetes Metab · Meta-analysis · n=2145 — The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE-Assessed Systematic Review and Meta-Analysis
  2. Hadi 2021 · Phytother Res · RCT · n=43 — Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial

Allergic rhinitis

BeneficialGrade B · Moderate evidence
Studies (1)
  1. Majeed 2024 · Medicine (Baltimore) · RCT · n=65 — A randomized, double-blind, placebo-controlled study to evaluate the benefits of a standardized Nigella sativa oil containing 5% thymoquinone in reducing the symptoms of seasonal allergy

High blood pressure

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Musazadeh 2026 · Endocrinol Diabetes Metab · Meta-analysis · n=2145 — The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE-Assessed Systematic Review and Meta-Analysis
  2. Hadi 2021 · Phytother Res · RCT · n=43 — Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial

High triglycerides

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Rounagh 2024 · Clin Nutr ESPEN · Meta-analysis · n=2278 — Effects of Nigella sativa supplementation on lipid profiles in adults: An updated systematic review and meta-analysis of randomized controlled trials
  2. Hadi 2021 · Phytother Res · RCT · n=43 — Effect of Nigella sativa oil extract on cardiometabolic risk factors in type 2 diabetes: A randomized, double-blind, placebo-controlled clinical trial

Body weight and body fat

Mixed resultsGrade B · Moderate evidence
Studies (1)
  1. Musazadeh 2026 · Endocrinol Diabetes Metab · Meta-analysis · n=2145 — The Effect of Nigella sativa Supplementation on Cardiometabolic Health in Patients With Metabolic Diseases: A GRADE-Assessed Systematic Review and Meta-Analysis

Inflammation markers (such as CRP)

Mixed resultsGrade B · Moderate evidence
Studies (2)
  1. Mohit 2020 · Complement Ther Med · Meta-analysis — Effect of Nigella sativa L. supplementation on inflammatory and oxidative stress indicators: A systematic review and meta-analysis of controlled clinical trials
  2. Jamshidian 2026 · J Obstet Gynaecol Res · RCT · n=60 — Nigella sativa (Black Seed) Oil Alleviates the Serum Levels of IL-6 and Insulin in Patients With Polycystic Ovary Syndrome

Mechanisms of action

Mast cell membrane stabilization and degranulation blockade

★★★☆☆Mechanism evidence: grade CSecondary target

In animal studies, thymoquinone can lower plasma mast cell protease markers in an allergy model, which suggests it can affect mast cell mediator release. However, studies of allergy symptoms in humans cannot by themselves show that mast cell degranulation is directly inhibited, and the direct effect and its strength in humans are still unclear.

References (2)
  1. Duncker et al. 2012 · Mouse food allergy model: oral thymoquinone lowered plasma mast cell protease markers
  2. Literature search found no direct study · Conclusion: studies of allergy symptoms in humans cannot by themselves show that mast cell degranulation is directly inhibited

Nrf2/ARE activation of endogenous antioxidant enzymes

★★☆☆☆Mechanism evidence: grade CSecondary target

In animal studies, thymoquinone can promote Nrf2 nuclear translocation and increase HO-1 and NQO1, and cell studies have also observed similar HO-1 induction. However, the evidence for direct covalent modification of Keap1 is insufficient, and the effect in humans after routine oral intake has not been established.

References (2)
  1. 2020 · Mouse study: thymoquinone treatment increased Nrf2 nuclear translocation and HO-1 and NQO1; this study used intraperitoneal administration
  2. 2014 · Cell study in human keratinocytes: Nrf2/ARE-related HO-1 induction was observed

Inhibition of NF-κB / AP-1, the master switches of pro-inflammatory transcription

★★☆☆☆Mechanism evidence: grade CSecondary target

A mouse study showed that oral thymoquinone can reduce phosphorylation of p65 and IκBα in inflamed tissue, which suggests some modulation of the NF-κB pathway. This result comes from an animal model, and an effect in humans at routine oral exposure has not yet been confirmed.

References (1)
  1. 2017 · Mouse study: oral thymoquinone reduced phosphorylation of p65 and IκBα in inflamed tissue

Direct inhibition of cyclooxygenase and lipoxygenase (COX-2 / 5-LOX) activity

★★☆☆☆Mechanism evidence: grade DSecondary target

In vitro, thymoquinone can inhibit 5-lipoxygenase and enzymes involved in leukotriene synthesis. Its target engagement and effect strength after oral intake in humans are unclear, and no reliable study shows that usual oral doses directly inhibit COX-2 or 5-LOX enzyme activity in humans.

References (2)
  1. Mansour and Tornhamre 2004 · In-vitro study in human blood cells: thymoquinone inhibited 5-LOX and enzymes related to leukotriene synthesis
  2. Literature search found no direct study · Conclusion: no reliable study has shown that usual oral doses directly inhibit COX-2 or 5-LOX enzyme activity in humans

Safety and drug interactions

Large doses are not recommended in pregnancy, as it may weakly stimulate uterine smooth muscle, and safety data in pregnancy are insufficient. People with low blood pressure or taking antihypertensive drugs should monitor their blood pressure. People taking glucose-lowering drugs, antihypertensives, anticoagulants or antiplatelet drugs should watch for additive drug effects.

Low blood pressure risk

Can mildly lower blood pressure. Each of these lowers blood pressure to some degree. People who combine several, whose blood pressure is already low, or who take blood pressure medication may feel dizzy or weak when standing up.

Open in the interactive app ›